Invitra AT™ is a biological acellular product derived from human amnion. Amniotic tissue is comprised of an extracellular matrix that forms a natural scaffold. Amniotic tissue has a series of anti-inflammatory, anti-bacterial, anti-viral properties as well as low immunogenicity. This natural scaffold works as a physical barrier that can contain cells to an affected area by maintaining adhesion of cells.
Invitra AF™ is a biological acellular product derived from the human amnion. Amniotic fluid is rich in growth factors and cytokines including growth factor (EGF), transforming growth factor alpha (TGF alpha), transforming growth factor beta-1, and insulin-like growth factor 1 (IGF1). Importantly, amniotic fluid contains factors related to the innate immune system including a spectrum of antimicrobials effective against bacteria, fungi, protozoa, and viruses.
Invitra AT™ & AF™ is processed from donated umbilical cords from full term deliveries. All donors are pre-screened and undergo comprehensive testing that includes:
- Behavioral risk assessment
- Physical assessment
- Donor medical history
- Communicable disease testing